Cargando…
Association between tirofiban monotherapy and efficacy and safety in acute ischemic stroke
BACKGROUND: Studies have suggested that glycoprotein IIb/IIIa antagonists such as tirofiban are beneficial for patients with acute coronary syndromes. However, it is still uncertain about the efficacy and safety of tirofiban in patients with acute ischemic stroke (AIS). METHODS: In this prospective...
Autores principales: | Tao, Chunrong, Zhu, Yuyou, Zhang, Chao, Song, Jianlong, Liu, Tianlong, Yuan, Xiaodong, Luo, Wenwu, Chen, Changchun, Liu, Dezhi, Zhu, Yuanyuan, Liu, Jie, Hu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223269/ https://www.ncbi.nlm.nih.gov/pubmed/34167477 http://dx.doi.org/10.1186/s12883-021-02268-8 |
Ejemplares similares
-
Efficacy and Safety of Tirofiban in Clinical Patients With Acute Ischemic Stroke
por: Han, Bin, et al.
Publicado: (2022) -
Safety and Efficacy of Tirofiban Combined With Mechanical Thrombectomy Depend on Ischemic Stroke Etiology
por: Sun, Chao, et al.
Publicado: (2019) -
Safety and Efficacy of Tirofiban in Severe Ischemic Stroke Patients Undergoing Mechanical Thrombectomy
por: Cai, Lingxin, et al.
Publicado: (2022) -
Safety and Efficacy of Tirofiban for Acute Ischemic Stroke Patients With Large Artery Atherosclerosis Stroke Etiology Undergoing Endovascular Therapy
por: Huo, Xiaochuan, et al.
Publicado: (2021) -
The efficacy and safety of tirofiban for patients with acute ischemic stroke: A protocol for systematic review and a meta-analysis
por: Niu, Jiali, et al.
Publicado: (2019)